11:11 AM EST - Satellos Bioscience Inc. : Today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical and scientific community during a panel discussion at PPMD's 30th Annual Conference being held from June 27–29, 2024 in Orlando, Florida. Satellos Bioscience Inc.
shares T.MSCL are trading unchanged at $0.52.
